Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Antidepressant Efficacy of the Anticholinergic Scopolamine

NCT00369915 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.

NCT NCT00369915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00369915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Antidepressant Efficacy of the Anticholinergic Scopolamine
Lead sponsor
National Institute of Mental Health (NIMH)
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2006
Completion date
January 31, 2013
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, unipolar depression